Actively Recruiting

Phase 3
Age: 18Years - 45Years
FEMALE
NCT05462704

Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy

Led by Women and Infants Hospital of Rhode Island · Updated on 2025-06-10

300

Participants Needed

8

Research Sites

219 weeks

Total Duration

On this page

Sponsors

W

Women and Infants Hospital of Rhode Island

Lead Sponsor

H

Hasbro Children's Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

Double blind, placebo controlled, multicenter randomized trial in pregnant women in the U.S. (N=300) to test the central hypothesis that IV iron in pregnant women with IDA (Hb\<11 g/dL and ferritin\<30 ng/mL) at 13 - 30 weeks will be effective, safe and cost-effective in reducing severe maternal morbidity-as measured by maternal anemia at delivery-and will also improve offspring neurodevelopment.

CONDITIONS

Official Title

Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy

Who Can Participate

Age: 18Years - 45Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Pregnant women between the ages of 18-45
  • Singleton gestation
  • Iron-deficiency anemia with serum ferritin less than 30 ng/mL and hemoglobin less than 11 g/dL
  • Between 13 and 30 weeks of pregnancy
  • Plan to deliver at a participating hospital
Not Eligible

You will not qualify if you...

  • Anemia not caused by iron deficiency such as thalassemia, sickle cell disease, B12 or folate deficiency, or hypersplenism
  • Conditions affecting iron absorption like malabsorptive syndrome, inflammatory bowel disease, or gastric bypass
  • Sensitivity to oral or intravenous iron
  • Multiple pregnancies (twins or more)
  • Unable or unwilling to provide informed consent
  • Unable to communicate with the study team even with an interpreter
  • Planning to deliver at a hospital not affiliated with the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 8 locations

1

University of Alabama Medical Center

Birmingham, Alabama, United States, 35401

Actively Recruiting

2

GNP Research at Heme-on-Call

Miami, Florida, United States, 33143

Actively Recruiting

3

Michigan University Medical Center

Ann Arbor, Michigan, United States, 48109

Actively Recruiting

4

Washington University Medical Center

St Louis, Missouri, United States, 65105

Actively Recruiting

5

Oregon Health and Sciences Uiversity Medical Center

Portland, Oregon, United States, 97239

Actively Recruiting

6

Hasbro Children's Hospital

Providence, Rhode Island, United States, 02905

Actively Recruiting

7

Women & Infants Hospital of Rhode Island

Providence, Rhode Island, United States, 02905

Actively Recruiting

8

University of Utah Hospital

Salt Lake City, Utah, United States, 84132

Actively Recruiting

Loading map...

Research Team

C

Crystal Ware, BSN, CCRP

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here